Morrisons reported a 3.2% increase in like-for-like sales for the 13 weeks to July 26, accelerating from 2.2% in the prior quarter. This growth, driven by continued price cuts, signals intensifying competition in the UK supermarket sector, posing challenges for listed rivals Tesco and Sainsbury. The broader market remains subdued, with total sales growth lagging inflation, but Morrisons outperformed peers. Attention now shifts to Tesco's upcoming half-year results, with expectations of sharper competition and uncertain grocery inflation ahead.
Morrisons' recent sales growth is notable for readers tracking UK supermarkets. For readers following consumer staples, here is Pluang's market snapshot as of Sep 17, 2026 23:44 WIB: Out of 46 priced US consumer staples stocks, 26 rose and 19 fell. Estee Lauder Companies Inc (EL) traded at USD 94.24 with a 1-day change of -1.42%, Anheuser-Busch Inbev SA (BUD) was at USD 78.83 down 1.34%, and Albertsons Companies Inc (ACI) rose 1.31% to USD 12.72 with 100% sell order activity and a typical hold time of 41 days on Pluang.
KB Home is set to report its Q3 2026 earnings on September 22, with analysts projecting a 45.3% drop in earnings per share to around $0.89 and a 20.2% decline in revenue to about $1.30 billion compared to last year. The consensus EPS estimate has rec...
An investment of $10,000 in Nebius when it resumed trading in 2024 has grown significantly to approximately $105,000 by 2026. This remarkable increase highlights Nebius's strong market performance over the two-year period. Investors who bought in at ...
W.P. Carey expects to invest over $1.9 billion in 2026, reflecting robust growth in its net lease property portfolio. Despite a slight reduction in its price target by Scotiabank to $76, the stock still shows potential upside from current levels. The...
Micron Technology is investing $10 billion over the next decade to establish Micron Research Labs, a new division focused on future memory architectures and advanced semiconductor manufacturing. The company shows strong financial health with a low de...
Impact Biomedical Inc. will conduct a 1-for-12.62 reverse stock split on September 23, 2026, consolidating shares without changing shareholder value. This move facilitates its planned merger with Zoar Ltd., with a Form F-4 registration filed with the...
